We report the case of a 7-year-old male of Western European origin presenting with moderate intellectual disability, severe childhood apraxia of speech in the presence of oral and manual dyspraxia, and hypotonia across motor systems including the oral and speech motor systems. Exome sequencing revealed a de novo frameshift protein truncating mutation in the fourth exon of BCL11A, a gene recently demonstrated as being involved in cognition and language development.
| INTRODUCTION
Numerous genetic factors contribute to speech and language development and impairment (Barnett & van Bon, 2015; Graham & Fisher, 2015) . In the most recent analysis of the Deciphering Developmental Disorders (DDD) study (Deciphering Developmental Disorders Study, 2015) , the extent of speech delay in patients with developmental disorders has been shown to statistically increase the likelihood of finding a damaging de novo mutation (Deciphering Developmental Disorders Study, 2017) . Most of these mutations have a global, unspecific impact on speech development. However, some have an effect on specific aspects of language such as FOXP2 (Morgan, Fisher, Scheffer, & Hildebrand, 2016; Reuter et al., 2017) or GRIN2A (Lai, Fisher, Hurst, Vargha-Khadem, & Monaco, 2001; Myers & Scheffer, 2016; Turner et al., 2015) anomalies, which lead to childhood apraxia of speech, oral motor dyspraxia, and dysarthria, or SETBP1 encompassing 18q12.3 deletions which seems to impact expressive language, while preserving receptive language (Filges et al., 2011; Marseglia et al., 2012) .
The B-cell lymphoma/leukemia 11A (BCL11A) gene encodes a C2H2 zinc-finger transcription factor highly expressed in the brain and the adult erythroid lineage (Avram, Fields, Senawong, Topark-Ngarm, & Leid, 2002; Leid et al., 2004; Nakamura et al., 2000) , and is part of the murine BAF swi/snf chromatin remodeling complex (Kadoch et al., 2013) . BCL11A has been shown to be a critical modulator of hemoglobin switching and HbF silencing (Basak et al., 2015; Funnell et al., 2015; Guda et al., 2015; Xu et al., 2013) . In the murine brain, Bcl11a controls cell polarity, radial migration of upper cortical neurons, axon branching, and dendrite outgrowth (Kuo, Chen, & Hsueh 2010; Kuo, Hong, & Hsueh, 2009; Kuo, Hong, Chien, & Hsueh, 2010b; Wiegreffe et al., 2015) . The DDD project (Deciphering Developmental Disorders Study, 2015; Dias et al., 2016) demonstrated that BCL11A haploinsufficiency causes intellectual disability and language delay (OMIM #617101). Patients with BCL11A mutations have global developmental delay, intellectual disability, which is moderate in most cases, and language delay of variable severity, with the occurrence of first words ranging from 16 months (mild) to only two words at the age of 6 years (severe). Microcephaly, autism spectrum disorder, and mild dysmorphism can be present and the level of fetal Hb is raised. In addition, BCL11A is included in most CNVs reported as the 2p15-p16.1 microdeletion syndrome (OMIM #612513), characterized by developmental delay, intellectual disability, hypotonia, poor verbal skills, craniofacial and skeletal features, digital anomalies, and fetal hemoglobin persistence (Basak et al., 2015; Funnell et al., 2015) .
When described, patients with 2p15p16 microdeletion encompassing BCL11A show delayed receptive and expressive language skills (Hancarova et al., 2013; Piccione et al., 2012; Rajcan-Separovic et al., 2007) , language delay (Balci, Sawyer, Davila, Humphreys, & Dyment, 2015; Felix, Petrin, Sanseverino, & Murray, 2010) , language restricted to a few single words and signing (Florisson et al., 2013) , or absence of language (Florisson et al., 2013; Hucthagowder et al., 2012) . Apart from Peter, Matsushita, Oda, and Raskind, (2014) , who described a 200 kb 2p15p16.1 deletion encompassing the entire BCL11A gene (plus 50 kb of non-coding sequence but no other known coding or non-coding gene) in a patient with mild intellectual disability, childhood apraxia of speech, dysarthria, and oral and motor dyspraxia, language anomalies have not been extensively studied in patients with mutations or microdeletions affecting BCL11A.
In this report, we describe a boy with a single base de novo deletion in exon 4, causing a frameshift protein truncating mutation of BCL11A. The patient presents with a phenotype strikingly similar to the patient described by Peter et al. (2014) , as it combines severe childhood apraxia of speech, gross and fine motor impairment, and moderate intellectual delay.
| Clinical report
The patient is the second of two children born to a nonconsanguineous couple of Western European origin with no family history of neurodevelopmental disorders. He was born after an uneventful pregnancy and a normal delivery. Birth parameters were normal (weight 3,300 g, head circumference 33.5 cm, length 49 cm) and no congenital anomaly was observed. Growth parameters evolved within normal limits except for progressive mild microcephaly (50 cm at 7 years old, 1st Centile, −2.32 SD). He had global developmental delay: he sat unsupported at 11 months, walked at 24 months of age, and had an important language delay.
Parents first sought specialized medical care when the patient was 13 months old. At that time, physical examination was normal apart from discrete facial dysmorphism consisting of bilateral epicanthi, sparse eyebrows, a wide mouth with full lips, full tip of the nose, discrete retrognathia, fine hair with high frontal and posterior hairline, and a frontal upsweep, everted upper part of the ears, prominent antihelix, deep fossa, and small attached ear lobe (Figures 1b and 1c ).
Neurological examination revealed axial and oral hypotonia with excessive drooling. The patient had good social competences, smiling often and presenting good eye contact.
Physical and speech therapy was initiated at the age of 3; at that time the patient's vocabulary was limited to three words. At the age of four and a half he was able to make full sentences, still producing "me"/"I" substitutions occurring in the French equivalents of these words. The patient was having difficulties when conjugating verbs. He could count to three, but was unable to recognize colors. He was placed in a special education program.
Full cognitive testing was performed at the age of 5. General intellectual ability was evaluated using the French version of the Wechsler preschool and primary scale of intelligence (WPPSI-III) (Wechsler, 2002) resulting in an intelligence quotient of 53 with substantial inhomogeneity between subtests. The patient achieved relatively good scores in logical reasoning (score of 8), picture concepts (score of 5), and word reasoning (score of 5), but had very low scores in information and vocabulary (both a score of 1), block design (testing visual perception, organization, and visual-motor coordination; score of 1), and coding (testing visual-motor processing speed and shortterm memory; score of 2) (for details, see Table 1 ).
When the patient was 7 years old, orofacial praxis (non speech articulatory postures), speech, and language assessments were performed using the following French batteries: the Hénin-Dulac scale (Henin, 1978) for orofacial praxis, EXALang 5-8 (Thibault, Helloin, & Croteau, 2003) for speech and ELO (Khomsi, 2001 ) for language (see methods and Table 1 ).
Orofacial praxis was severely impaired (under 2nd percentile for all subtests), characterized by either very weak or impossible imitation, the occurrence of many facial synkinesia (e.g., raising eyebrows when asked to rise up the tongue) and frequent automatic-voluntary dissociation of oro-facial gestures (e.g., being unable to use tongue on demand but able to protrude tongue in the context of natural observation), clearly supporting the hypothesis of impaired motor programming.
Speech was characterized by inaccurate speech sound production (under 1st percentile); in particular, we observed the frequent occurrence of errors of resonance (nasalization/oralization), devoicing phenomenon, and final consonant deletion within the word. The patient produced vowels accurately in isolation but not always in the context of connected speech. On a dynamical point of view, there was an inconsistency of production, with the occurrence of multiple inaccurate speech sound productions within a same word, the latest being more frequently observed in the context of a directed task rather than during natural speech (automatic-voluntary dissociation), and the occurrence of increased error rates in longer and/or more complex word shapes. The phonetic inventory was still reduced. In isolation, the patient could not produce fricatives
Instead, he produced a substitutive interdental sound. In connected speech, when a fricative phoneme was the last syllable of a word, the substitutive interdental sound was not produced, annulling the last syllable.
Furthermore, voice sounded breathy and weak and was characterized by a high vocal pitch, and intermittent hyper nasality, resulting in low speech intelligibility. Such voice could result from weakness of phonatory gesture suggesting dysarthria. The global linguistic profile (lexicon at 16th percentile and morphosyntax at 4th percentile) was characterized by a homogeneous moderate deficit, similar to the one observed in terms of the child's developmental age.
From the patient's phenotype, the following signs/symptoms are consistent with childhood apraxia of speech as described in the American Speech Language Hearing Association (ASHA) technical (Figures 1d and 1e) . This deletion induces a frameshift predicted to lead to a premature stop codon, p.Pro448Argfs*31. Deep amplicon sequencing revealed no mosaicism in the parents at coverage of more than 4000x. Because of the known role of BCL11A on hemoglobin switching and HbF silencing, hemoglobin electrophoresis and quantification were performed, which detected elevated HbF at 4.4% and 4.5% (Normal <1.5%) on two successive measures (6 months interval) without any other hematological abnormalities (Hb: 12.7 g/dl; vitamin B12, ferritin: normal).
| METHODS
The parents gave written consent for them and written permission for the patient to participate in the ADrESSE exome sequencing study and blood sampling being performed for DNA extraction (approved by local Hôpital Erasme and HUDERF Children Hospital Ethical committees under P2013/206 reference).
Orofacial praxis (non speech articulatory postures) was formally examined using the Hénin-Dulac scale, during which the patient is asked through a verbal order and imitation to mobilize sequentially tongue, lips, cheek, mandible, eyelid, and finally forehead (Henin, 1978) . Speech was evaluated using EXALang 5-8 (Thibault et al., 2003) , involving the child in a speaking task that requires single postures versus sequences of postures (at syllable, single-word, bisyllable, multisyllable levels). Language was evaluated with the batterie ELO (Examen du Langage Oral) (Khomsi, 2001 ). Voice quality has been subject to perceptual judgment by an expert clinician. Consistent with murine models and BCL11A mutated patients described by Dias et al. (2016) , our patient has progressive microcephaly, with a head circumference at the 1st percentile (−2.32 SD). Repeated brain MRI at 1.5 and 3 Tesla failed to demonstrate any CNS structural anomaly, similar to patients with missense and LoF mutations of BCL11A (Dias et al., 2016) , but dissimilar to patients with the 2p15-p16.1 microdeletion syndrome, for which at least three genes have been shown to participate to the brain malformation phenotype in zebrafish models (Bagheri et al., 2016) . Our patient did not meet the diagnostic criteria of ASD, concordant with the low frequency of ASD in the 11 reported patients (Dias et al., 2016) . Our patient had manual dyspraxia, a feature scarcely reported in patients with microdeletions encompassing BCL11A (Basak et al., 2015) .
Speech and language delay is recognized as a key feature of the BCL11A LoF and missense mutations, and BCL11A encompassing 2p15p16 microdeletion syndromes (see introduction). But except for one report (Peter et al., 2014 ) and the present case, it has only been briefly depicted. Peter et al. (2014) reported an 11 year old boy with a 203 kb 2p16.1 microdeletion encompassing only the BCL11A gene (NCBI36: chr2:60.7-60.8). Peter's patient and ours present a strikingly similar speech disorder: both patients presented phonemic alterations, with deletion of consonants and syllables, phonemic substitutions (our patient), vowels errors increasing with phonetic complexity (both), and low speech intelligibility (both), all consistent with childhood apraxia of speech.
On a mechanistic point-of-view, we noticed that both patients presented with oral-motor dysfunction, excessive drooling (also reported in the patient of Rajcan-Separovic et al. (2007) , difficult chewing, weak articular contact, and a breathy speech, all suggestive of dysarthria. In addition, intermittent hypernasality was observed in both patients. BCL11A is a known interactor of COUP-TF1 and COUP-TF1 knockout in mice results in malformations of the glossopharyngeal ganglion (Avram et al., 2000 (Avram et al., , 2002 Qiu et al., 1997) . In humans the glossopharyngeal nerve and ganglion are responsible for motor (stylopharyngeal) and sensory innervation of the upper pharynx, and parasympathetic innervation of the parotid gland (Sarrazin, Toulgoat, & Benoudiba, 2013) .
Hence, the hypothesis of BCL11A mediating a dysfunction of the glossopharyngeal nerve could, at least partially, explain the oropraxic and phonological deficits and excessive drooling present in the described patients.
BCL11A has been recently suggested by a proteomics study to be part of the BAF swi/snf chromatin remodeling complex (Kadoch et al., 2013) . Dias et al. (2016) showed differential expression of BAF swi/snf related genes in the hippocampus of Bcl11a haploinsufficient mice, suggesting that BCL11A is a BAFopathy gene. In this context, it is noticeable that, before performing research exome sequencing, the unique gene we selected for clinical Sanger sequencing, based on dysmorphology criteria present in our patient, was ARID1B, a classic BAFopathy gene (Hoyer et al., 2012) .
BCL11A is known to be a repressor of fetal hemoglobin expression. Patients with missense and LoF mutations (Dias et al., 2016) , or BCL11A encompassing 2p15p16 microdeletions (Basak et al., 2015; Funnell et al., 2015) were shown to have elevated fetal hemoglobin levels, ranging from 3.1% (Dias et al., 2016) to 29.7% (Basak et al., 2015) . Our patient value of 4.5% of HbF is thus in accordance with reported cases and constitutes additional evidence for the pathogenic nature of the LoF variant observed in our patient. As the neurodevelopmental deleterious effects of BCL11A haploinsufficiency are now established, marked caution should be applied in the evaluation of BCL11A inhibitors as therapeutic options for hemoglobinopathies such as sickle-cell disease or thalassemia (Bauer, Kamran, & Orkin, 2012 ).
In conclusion, our case and the one of Peter et al. (2014) demonstrate a strikingly similar phenotype of dysarthria and childhood apraxia of speech associated with BCL11A haploinsufficiency. While
Peter's patient had a deletion of BCL11A and 50 kb of non-coding sequence, our case is a LoF mutation, strongly suggesting that BCL11A haploinsufficiency is responsible for the language phenotype of both patients. In-depth language description of more patients with BCL11A missense and LoFs variants is needed to assess whether these speech disorder phenotypes are major components of the BCL11A related syndrome, or anecdotic features present in a minority of patients.
Excessive drooling reported in at least three patients does suggest that dysarthria and oro-praxic symptoms could also be specific to BCL11A haploinsufficiency, possibly through glossopharyngeal nerve dysfunction.
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